Angioedema due to ACE inhibitors: common and inadequately diagnosed.
The estimated incidence of angioedema during angiotensin-converting enzyme (ACE) inhibitor treatment is between 1 and 7 per thousand patients.  This potentially serious adverse effect is often preceded by minor manifestations that may serve as a warning.
D000328:Adult; D000799:Angioedema / Q000139:chemically induced* / Q000175:diagnosis; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001315:Australia; D004656:Enalapril / Q000009:adverse effects; D005060:Europe; D006801:Humans; D017706:Lisinopril / Q000009:adverse effects; D013548:Sweden
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D017706:Lisinopril